Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fazirsiran for Liver Disease Associated with Alpha 1 -Antitrypsin Deficiency
Pavel Strnad, Mattias Mandorfer, Gourab Choudhury, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 6, pp. 514-524
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Jillian Belgrad, Hassan H. Fakih, Anastasia Khvorova
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 2, pp. 52-72
Closed Access | Times Cited: 32
Adeno-associated viruses for gene therapy – clinical implications and liver-related complications, a guide for hepatologists
Marcus M. Mücke, Sylvia Fong, Graham R. Foster, et al.
Journal of Hepatology (2023) Vol. 80, Iss. 2, pp. 352-361
Open Access | Times Cited: 22
Nanoparticles and siRNA: A new era in therapeutics?
María Dolores Pérez‐Carrión, Inmaculada Posadas, Valentı́n Ceña
Pharmacological Research (2024) Vol. 201, pp. 107102-107102
Open Access | Times Cited: 14
EASL Clinical Practice Guidelines on genetic cholestatic liver diseases
Henkjan J. Verkade, Antonia Felzen, Verena Keitel, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 303-325
Closed Access | Times Cited: 10
MetALD: Does it require a different therapeutic option?
George Marek, Harmeet Malhi
Hepatology (2024) Vol. 80, Iss. 6, pp. 1424-1440
Closed Access | Times Cited: 8
Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency
Natalia Brzozowska, Lily Wu, Vera Khodzhaeva, et al.
Nature Genetics (2025)
Open Access | Times Cited: 1
Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA)
Virginia Clark, Charlie Strange, Pavel Strnad, et al.
Gastroenterology (2024) Vol. 167, Iss. 5, pp. 1008-1018.e5
Open Access | Times Cited: 7
Therapeutic modulation of the liver immune microenvironment
Herbert Tilg, Timon E. Adolph, Frank Tacke
Hepatology (2023)
Closed Access | Times Cited: 15
Gene therapy for alpha-1 antitrypsin deficiency: an update
Debora Ferreira, Alisha M. Gruntman, Terence R. Flotte
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 3, pp. 283-291
Open Access | Times Cited: 13
Alpha-1 antitrypsin deficiency
Francisco Dası́
Medicina Clínica (2023) Vol. 162, Iss. 7, pp. 336-342
Open Access | Times Cited: 13
Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency
Alice Turner, Joachim H. Ficker, Andrea Vianello, et al.
Therapeutic Advances in Respiratory Disease (2025) Vol. 19
Open Access
Alpha 1-antitrypsin deficiency and primary liver cancers
Carolin V. Schneider, Marie Decraecker, Aurélie Beaufrère, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189290-189290
Open Access
Diagnosis and Monitoring Pathways Using Non‐Invasive Tests in Patients With Alpha‐1 Antitrypsin Deficiency‐Associated Liver Disease: Results From an Expert Delphi Panel
Virginia Clark, Mark Price, Jon Russo, et al.
United European Gastroenterology Journal (2025)
Open Access
Severe alpha-1 antitrypsin deficiency shows a higher risk of complications after first decompensation compared to other aetiologies of cirrhosis☆
Lorenz Balcar, Malin Fromme, Naomi Kappe, et al.
JHEP Reports (2025), pp. 101398-101398
Open Access
Targeting the Liver with Nucleic Acid Therapeutics for the Treatment of Systemic Diseases of Liver Origin
Anagha Gogate, Jordyn Belcourt, Milan Shah, et al.
Pharmacological Reviews (2023) Vol. 76, Iss. 1, pp. 49-89
Open Access | Times Cited: 12
Genetics of liver disease in adults
Chigoziri Konkwo, Shanin Chowdhury, Sílvia Vilarinho
Hepatology Communications (2024) Vol. 8, Iss. 4
Open Access | Times Cited: 4
RNA-based therapies in liver metabolic diseases
Antonio Fontanellas, Pedro Berraondo, F Urigo, et al.
Gut (2025), pp. gutjnl-331742
Open Access
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
M.A. Karsdal, Thomas R. Cox, Amelia L. Parker, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 1856-1856
Open Access
Liver Disease and Prevalence of Liver Transplantation in Adults With ZZ Alpha‐1 Antitrypsin Deficiency—A Meta‐Analysis
Adam M. Syanda, Dimitra Georgantaki, Muhammad Awsaf, et al.
Liver international communications. (2025) Vol. 6, Iss. 2
Open Access
Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicine
Malin Fromme, Fabienne Klebingat, Paul Ellis, et al.
Hepatology Communications (2025) Vol. 9, Iss. 5
Open Access
Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectors
Antoine Gardin, Giuseppe Ronzitti
Archives de Pédiatrie (2023) Vol. 30, Iss. 8, pp. 8S46-8S52
Closed Access | Times Cited: 10
NEAT1–SOD2 Axis Confers Sorafenib and Lenvatinib Resistance by Activating AKT in Liver Cancer Cell Lines
Hiroyuki Tsuchiya, Ririko Shinonaga, Hiromi Sakaguchi, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 2, pp. 1073-1085
Open Access | Times Cited: 9
Alpha-1 antitrypsin deficiency: current therapy and emerging targets
Oisín F. McElvaney, D. Fraughen, Oliver J. McElvaney, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 3, pp. 191-202
Closed Access | Times Cited: 9
Editing approaches to treat Alpha-1 Antitrypsin Deficiency (AATD)
Derek M. Erion, L. Liu, Christopher R. Brown, et al.
CHEST Journal (2024)
Closed Access | Times Cited: 3
Longitudinal evaluation of individuals with severe alpha-1 antitrypsin deficiency (Pi*ZZ genotype)
Malin Fromme, Audrey Payancé, Mattias Mandorfer, et al.
Gastroenterology (2024)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top